We serve Chemical Name:4-(1H-imidazol-2-yl)piperidine CAS:647024-44-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(1H-imidazol-2-yl)piperidine
CAS.NO:647024-44-0
Synonyms:4-(1H-imidazol-2-yl)piperidine
Molecular Formula:C8H13N3
Molecular Weight:151.20900
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:40.71000
Exact Mass:151.11100
LogP:1.20550
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-(1H-imidazol-2-yl)piperidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(1H-imidazol-2-yl)piperidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(1H-imidazol-2-yl)piperidine Use and application,4-(1H-imidazol-2-yl)piperidine technical grade,usp/ep/jp grade.
Related News: The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented. 4-(1H-imidazol-2-yl)piperidine manufacturer Retrogenix��s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding. 4-(1H-imidazol-2-yl)piperidine supplier ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment��s chemistry, manufacturing and controls process, but not its safety. 4-(1H-imidazol-2-yl)piperidine vendor Retrogenix��s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding. 4-(1H-imidazol-2-yl)piperidine factory The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.
